Key result
Perioperative magnesium infusion significantly reduced the incidence of atrial fibrillation compared to control (2% vs 36%, P<0.001) in patients undergoing CABG.
Why the study?
Does perioperative magnesium infusion reduce P-wave dispersion and the risk of atrial fibrillation in patients undergoing CABG?
Population
148 consecutive patients undergoing coronary artery bypass surgery
Comparison
1.5 g daily magnesium sulfate infusion applied… vs Control group (no magnesium infusion)
Design
RCT, randomly allocated
Follow-up
4 days following surgery
Authors
Loading...
Supports perioperative magnesium in CABG to lower AF risk; reinforces RCT evidence for postoperative arrhythmia prevention.
RCT (n=148)
randomly allocated
Does perioperative magnesium infusion reduce P-wave dispersion and the risk of atrial fibrillation in patients undergoing CABG?
Absolute Event Rate: 2% vs 36%
p-value: p=<0.001
Perioperative magnesium infusion significantly reduces P-wave dispersion and the incidence of postoperative atrial fibrillation in patients undergoing CABG.
Dağdelen et al. (2002) conducted an RCT in Coronary Artery Bypass Surgery (CABG) (n=148). Magnesium (MgSO4) infusion vs. Control was evaluated on Atrial fibrillation (p=<0.001). Perioperative magnesium infusion significantly reduced the incidence of atrial fibrillation compared to control (2% vs 36%, P<0.001) in patients undergoing CABG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: